Specialized Arab Hospital Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2012
NCT01946984
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Specialized Arab Hospital

Active Ingredients

Drugs in Phase 2 Trials (2)

chlorhexidine (hibitane) (1 trial)

water (1 trial)

Drugs in Phase 1 Trials (2)

diclofenac (voltaren) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gingivitis (Phase 2)

Pancreatitis (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4